Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27257820 | 0.85 | GRM1 (0.36) | — | |
| SCHEMBL416894 | 0.69 | KMT2A (0.37) | — | |
| SCHEMBL996039 | 0.69 | KMT2A (0.37) | — | |
| SCHEMBL6259101 | 0.69 | KMT2A (0.37) | — | |
| SCHEMBL11441416 | 0.69 | PTGS1 (0.37) | — | |
| SCHEMBL9530330 | 0.68 | LTA4H (0.39) | LTA4H | |
| SCHEMBL5001430 | 0.68 | GRM1 (0.34) | — | |
| Hydrochloric Acid SCHEMBL4678540 | 0.67 | KMT2A (0.36) | — | |
| Hydrochloric Acid SCHEMBL4678546 | 0.67 | KMT2A (0.36) | — | |
| Ammonia Solution, Strong SCHEMBL7204814 | 0.67 | TDP1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547210-A1 | MUTANASES AND ORAL CARE COMPOSITIONS COMPRISING SAME | Novozymes A/S (DK) | 2025-05-07 | — | — | EP | disclosed |
| EP-4482458-A1 | ORAL CARE COMPOSITION COMPRISING ENZYMES | Novozymes A/S (DK) | 2025-01-01 | — | — | EP | disclosed |
| EP-4447989-A1 | ORAL CARE COMPOSITION COMPRISING ENZYMES | Novozymes A/S (DK) | 2024-10-23 | — | — | EP | disclosed |
| WO-2024175631-A1 | ORAL CARE COMPOSITION COMPRISING INVERTASE | NOVOZYMES A/S (DK) | 2024-08-29 | — | — | WO | disclosed |
| WO-2024003143-A1 | MUTANASES AND ORAL CARE COMPOSITIONS COMPRISING SAME | NOVOZYMES A/S (DK) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023161245-A1 | ORAL CARE COMPOSITION COMPRISING ENZYMES | NOVOZYMES A/S (DK) | 2023-08-31 | — | — | WO | disclosed |
| EP-4199897-A2 | ORAL CARE COMPOSITION COMPRISING A FRUCTANASE | Novozymes A/S (DK) | 2023-06-28 | — | — | EP | disclosed |
| WO-2023110900-A1 | ORAL CARE COMPOSITION COMPRISING ENZYMES | NOVOZYMES A/S (DK) | 2023-06-22 | — | — | WO | disclosed |
| WO-2022043273-A2 | ORAL CARE COMPOSITION COMPRISING A FRUCTANASE | NOVOZYMES A/S (DK) | 2022-03-03 | — | — | WO | disclosed |